Sanofi US is the American subsidiary of Sanofi, a French multinational pharmaceutical company. The company traces its roots back to 1804 when the Maison L'Arquenay was established in Paris, France. Over the years, it has undergone several mergers and acquisitions to become one of the largest pharmaceutical companies globally.

Sanofi US operates its headquarters in Bridgewater, New Jersey. The campus spans over 110 acres and serves as the commercial hub for the company in the United States. It houses various departments, including research and development, manufacturing, sales, and marketing.

Sanofi US offers a diverse range of products and services in the pharmaceutical industry. Its main focus areas include cardiovascular diseases, diabetes, rare diseases, multiple sclerosis, vaccines, and consumer healthcare. The company develops and markets prescription drugs, vaccines, over-the-counter medications, and medical devices.

On a global scale, Sanofi operates in more than 100 countries. It has several noteworthy subsidiaries and joint ventures, such as Genzyme Corporation, a leading biotechnology company, and Sanofi Pasteur, a division specializing in vaccines. The company has formed strategic partnerships with other major players in the industry, including Regeneron Pharmaceuticals, to jointly develop and commercialize innovative therapies.

Sanofi is a major player in the global pharmaceutical market. In terms of global sales, it consistently ranks among the top pharmaceutical companies worldwide. It faces competition from other pharmaceutical giants like Pfizer, Novartis, and Johnson & Johnson.

However, Sanofi has a strong market position due to its extensive product portfolio, global presence, and ongoing research and development efforts. Over the years, Sanofi has achieved significant milestones and made strategic changes to boost its growth. In 2011, it acquired Genzyme Corporation, expanding its biotechnology capabilities.

The company has also focused on diversifying its business by investing in areas such as rare diseases and vaccines. Sanofi has continuously evolved its product lineup to address emerging healthcare needs and pursue new growth opportunities. As of the latest information available, Sanofi is a leading pharmaceutical company with a robust pipeline of innovative drugs and ongoing collaborations to address various therapeutic areas.

The company remains committed to providing healthcare solutions and driving scientific advancements to improve patients' lives